Sort:
Date
Filter:
All

3,646 result(s) found

Workday (WDAY), Google Team Up to Develop AI Native Application https://www.zacks.com/stock/news/2283550/workday-wday-google-team-up-to-develop-ai-native-application?cid=CS-ZC-FT-analyst_blog|company_news_tech_sector-2283550 Jun 04, 2024 - Workday (WDAY) integrates Google Cloud's Vertex AI and Gemini models to support enterprises with customized AI-powered application development for business-specific requirements.
Agios (AGIO) Up 21% on Upbeat Data From 2nd Thalassemia Study https://www.zacks.com/stock/news/2283565/agios-agio-up-21-on-upbeat-data-from-2nd-thalassemia-study?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2283565 Jun 04, 2024 - Data from a late-stage study shows that transfusion-dependent thalassemia patients who received Agios' (AGIO) Pyrukynd demonstrated a statistically significant reduction in transfusion burden.
Kirby (KEX) Is Up 1.45% in One Week: What You Should Know https://www.zacks.com/stock/news/2283485/kirby-kex-is-up-1-45-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2283485 Jun 04, 2024 - Does Kirby (KEX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Why BJ's Wholesale Club Stock Was Up 18% Last Month https://www.fool.com/investing/2024/06/04/why-bjs-wholesale-club-stock-was-up-18-last-month/?source=iedfolrf0000001 Jun 04, 2024 - The company showed retail investors and analysts what they wanted to see.
Affimed (AFMD) Soars on Upbeat Follow-Up Data From NSCLC Study https://www.zacks.com/stock/news/2283535/affimed-afmd-soars-on-upbeat-follow-up-data-from-nsclc-study?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2283535 Jun 04, 2024 - Affimed (AFMD) rallies 69% on positive follow-up efficacy data from its early to mid-stage study of the AFM24/Tecentriq combo therapy to treat heavily-pretreated EGFR wild-type NSCLC patients.
Intellia (NTLA) Up on Upbeat Long-Term Angioedema Study Data https://www.zacks.com/stock/news/2283508/intellia-ntla-up-on-upbeat-long-term-angioedema-study-data?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2283508 Jun 04, 2024 - Intellia (NTLA) gains 10% after reporting encouraging long-term efficacy data from the phase I portion of its early to mid-stage study evaluating NTLA-2002 for treating hereditary angioedema.
United Natural (UNFI) Gears Up for Q3 Earnings: What to Expect? https://www.zacks.com/stock/news/2283395/united-natural-unfi-gears-up-for-q3-earnings-what-to-expect?cid=CS-ZC-FT-analyst_blog|earnings_preview-2283395 Jun 04, 2024 - United Natural's (UNFI) Q3 results are likely to reflect gains from transformation initiatives amid a volatile operating landscape.
Campbell Soup (CPB) Gears Up for Q3 Earnings: What to Expect? https://www.zacks.com/stock/news/2283390/campbell-soup-cpb-gears-up-for-q3-earnings-what-to-expect?cid=CS-ZC-FT-analyst_blog|earnings_preview-2283390 Jun 04, 2024 - Campbell Soup's (CPB) Q3 results are likely to reflect gains from strategic priorities and the Snacks business, while marketing costs and a tough consumer landscape are concerns.
The SBA is unveiling new credit lines of up to $5 million to fund small businesses https://www.cnbc.com/2024/06/04/sba-7a-working-capital-for-small-businesses.html Jun 04, 2024 - The project is part of the SBA's efforts to broaden its flagship lending program for American small businesses under Administrator Isabel Casillas Guzman.
Huge News for Spotify Stock https://www.fool.com/investing/2024/06/04/huge-news-for-spotify-stock/?source=iedfolrf0000001 Jun 04, 2024 - Prices are going up, and that's great for shareholders.
<<<Page 180>